ABVC BioPharma, Inc. (ABVC)

SG&A Expenses

$503.78K

Quarterly · Period ending: · USD

ABVC logo

ABVC SG&A Expenses

Latest reported$503.78K
ABVC Quarterly SG&A Expenses ($10.00K → $503.78K)
High-resolution chart · PNG

ABVC sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

ABVC BioPharma, Inc. SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
503,778
1,539,372
2,169,853
1,934,470
2,261,707
664,144
304,144
653,471
944,180
2,770,117
1,752,384
1,999,833
1,612,528
1,639,241
1,960,785
3,441,886
1,818,571
5,883,081
6,146,371
1,805,736
1,707,432
1,393,335
4,727,626
1,262,199
1,277,208
1,153,414
951,667
1,027,057
563,778
505,413
370,434
331,412
457,394
414,668
307,093
659,992
171,979
211,691
185,188
647,717
289,098
108,732
3,323
0
0
0
1,030
0
0
0
0
0
0
129,466
245,447
334,218
461,026
417,615
773,355
329,436
370,647
343,293
341,728
430,645
788,585
758,871
687,699
834,275
2,630,000
1,057,932
1,315,144
1,553,000
1,453,256
4,430,000
13,552
12,140
9,666
1,337
7,562
8,260
-480
6,646
4,107
7,301
4,946
7,460
7,327
3,365
10,000
10,000
10,000
0
10,000
10,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.